Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer

JAMA

Volumn 293, Issue 7, 2005, Pages 799-809

  Casey, Graham ^a   Lindor, Noralane M ^b   Papadopoulos, Nickolas ^c   Thibodeau, Stephen N ^b   Moskow, John ^c   Steelman, Scott ^c   Buzin, Carolyn H ^d   Sommer, Steve S ^d   Collins, Christine E ^c   Butz, Malinda ^b   Aronson, Melyssa ^e   Gallinger, Steven ^e   Barker, Melissa A ^f   Young, Joanne P ^f   Jass, Jeremy R ^g   Hopper, John L ^h   Diep, Anh ⁱ   Bapat, Bharati ^e   Salem, Michael ^c   Seminara, Daniela ^j   Haile, Robert ⁱ   more..

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c GMP Genetics Inc   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

^f Bancroft Centre   (Australia)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; DNA SEQUENCE; EXON; GENE DELETION; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MISMATCH REPAIR; MISSENSE MUTATION; PRIORITY JOURNAL; RNA SPLICING;

EID: 13844251880     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.7.799     Document Type: Article

References (23)

1. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-268.
2. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on hereditary nonpolyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
3. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-1456.
4. de la Chapelle A. 2002 William Allan Award address: inherited human diseases: victories, challenges, disappointments. Am J Hum Genet. 2003;72:236-240.
5. Lynch HT, de le Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-932.
6. International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer. Mutation database. Available at: http://www.insight-group.org. Accessibility verified January 19, 2005.
7. Yan H, Papadopoulos N, Marra G, et al. Conversion of diploidy to haploidy. Nature. 2000;403:723-724.
8. Nakagawa H, Yan H, Lockman J, et al. Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements. Cancer Res. 2002;62:4579-4582
9. Wagner A, Barrows A, Wijnen JT, et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet. 2003;72:1088-1100.
10. Lynch HT, Coronel SM, Okimoto R, et al. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA. 2004;291:718-724.
11. Marra G, D'Atri S, Yan H, et al. Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes. Cancer Res. 2001;61:7719-7721.
12. Liu T, Yan H, Kuismanen S, et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res. 2001;61:7798-7802.
13. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043-1048.
14. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
15. Papadopoulos N, Leach FS, Kinzler KW, Vogelstein B. Monoallelic mutation analysis (MAMA) for identifying germline mutations. Nat Genet. 1995;11:99-102.
16. Baudhuin LM, Mai M, French AJ, et al. Analysis of hMLH1 and HMSH2 gene dosage alterations in Lynch syndrome patients by novel methods. J Mol Diagn. In press.
17. Lynch HT, Coronel SM, Okimoto R, et al. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA. 2004;291:718-724.
18. Gille JJ, Hogervorst FB, Pals G, et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer. 2002;87:892-897.
19. Nakagawa H, Hampel H, de la Chapelle A. Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HN-PCC) by novel techniques. Hum Mutat. 2003;22:258.
20. Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat. 2003;22:428-433.
21. Baudhuin LM, Ming M, French AJ, et al. Analysis of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients by novel methods. J Molec Diagn. In press.
22. Liu B, Farrington SM, Petersen GM, et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med. 1995;1:348-352.
23. Jass JR. Clinical significance of early-onset "sporadic" colorectal cancer with microsatellite instability. Dis Colon Rectum. 2003;46:1305-1309.